TrimRx's Blog

Ozempic microdosing uses doses below 0.5mg weekly to minimize side effects while maintaining metabolic benefits — here’s the clinical evidence and safety

Ozempic microdosing safety depends on protocol adherence, but no clinical data supports doses below 0.25mg — here’s what prescribers actually recommend.

Semaglutide shows emerging evidence of anti-aging effects through improved metabolic health, reduced inflammation, and cellular stress protection beyond

Ozempic microdosing starts at 0.125–0.25mg weekly for gradual titration. Learn proper dose calculation, titration schedules, and safety protocols.

Semaglutide alters brain signaling in the hypothalamus and reward centers, reducing appetite and cravings while reshaping dopamine pathways.

Ozempic longevity data shows cardiovascular benefits beyond weight loss, reducing major cardiac events by 20% in trials. Here’s what the research means

Ozempic and Alzheimers research shows GLP-1 agonists may reduce neuroinflammation and amyloid plaque formation—early trials suggest 20-48% cognitive

Ozempic doesn’t directly treat nicotine addiction, but emerging data shows GLP-1 agonists may reduce addictive behaviors through dopamine pathway

Ozempic doesn’t cause chemical addiction, but dependency patterns emerge. Learn safe discontinuation protocols, rebound risks, and medically-supervised